Trump Media and Technology Group Corp vs Enveric Biosciences Inc — how do they compare? Trump Media and Technology Group Corp trades at $8.41 (market cap $2.48B), while Enveric Biosciences Inc trades at $1.58 (market cap $6.20M). The key difference: Trump Media and Technology Group Corp is far larger — about 400× Enveric Biosciences Inc's market cap. Which is the better fit depends on your goals.
| DJT | ENVB | |
|---|---|---|
Market Cap | $2.48B | $6.20M |
Sector | Media | Health |
52-Week High | $18.50 | $17.40 |
52-Week Low | $7.06 | $1.27 |
Enterprise Value | $2.54B | $1.30M |
Signals from Pluang's Aura AI — not financial advice
DJT stock declined 8.84% to $8.56 amid widening quarterly losses and negative technical momentum. The company reported a $238.1 million Q2 2026 net loss primarily from digital asset declines, despite 89% revenue growth to $1.67 million. Technical indicators show bearish momentum with price near key support at $8, while fundamental metrics reveal extreme valuation concerns with a P/S ratio of 547.62 and negative profit margins exceeding -28,000%.
The outlook remains challenging with persistent cash burn, unsustainable valuation multiples, and negative earnings trajectory. Investment opportunities appear limited given the company's minimal revenue base and ballooning losses, while risks include continued operational losses, digital asset volatility exposure, and competitive pressures in social media. Analyst sentiment remains overwhelmingly negative with Strong Sell ratings predominating.
ENVB trades at $1.56, up 1.3% on the day, with a bullish technical signal from moving averages and strong analyst support (75% buy ratings). The company reported four consecutive quarterly earnings beats in 2025, including a positive EPS of $0.85 in Q4, while recent news highlights progress in preclinical studies for its non-hallucinogenic psychiatric drug candidate EB-003.
Despite operational losses and negative ROE/ROA, ENVB's consistent earnings surprises and advancing pipeline present speculative growth potential. Key risks include cash burn, clinical trial outcomes, and regulatory hurdles, requiring careful risk assessment by investors.
Trailing returns across standard periods
Latest headlines on both assets
Trump Media & Technology Group is a media firm rooted in social media and digital streaming. Its flagship product, Truth Social, provides a platform focused on free speech and open conversation.
Read more on DJT →Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →